Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/1998
11/10/1998US5834478 Morphinan hydroxamic acid compounds
11/10/1998US5834470 Decongestants; bronchodilator and antisecretory and -tussive agents; side effect reduction
11/10/1998US5834469 Endothelin receptor antagonists
11/10/1998US5834438 Enhancement of gastric motility, prokinetic agents
11/10/1998US5834427 Novel amino acid sequence wherein the 25th arginine is replaced by cysteine, so that a dimer is formed by a disulfide bond; food or beverage additive for enhancing calcium or iron absorption
11/10/1998US5834419 Chemokine binding protein and methods of use therefor
11/10/1998US5834188 For inducing human osteogenic protein 1
11/10/1998US5834186 Regulatable RNA molecule
11/10/1998US5834002 Water insoluble gum base with water soluble bulk portion, flavors, colloidal bismuth salts of hydroxy carboxylic aicds, for treating helicobacter pylori infections, antiulcer agents
11/10/1998US5833990 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides
11/10/1998US5833953 Fluoridated micellar casein
11/09/1998CA2237052A1 Substituted diaminocarboxylic acids
11/07/1998CA2231754A1 A novel human g-protein coupled receptor hcept09
11/05/1998WO1998049319A1 Human lysophospholipase
11/05/1998WO1998049197A1 Oligopeptidic inhibitors of elastases and methods of preparation thereof
11/05/1998WO1998049170A1 Spiro-azacyclic derivatives and their use as therapeutic agents
11/05/1998WO1998049169A1 Phosphodiesterase 4-inhibiting diazepinoindolones
11/05/1998WO1998049166A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
11/05/1998WO1998049162A1 Sulfonamides for treatment of endothelin-mediated disorders
11/05/1998WO1998049152A1 Protease inhibitors
11/05/1998WO1998049131A1 New benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments
11/05/1998WO1998048827A1 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease
11/05/1998WO1998048815A1 Use of zinc hyaluronate against peptic ulcer
11/05/1998WO1998048814A1 Pourable alginate compositions
11/05/1998WO1998048799A1 Protease inhibitors
11/05/1998WO1998037094A3 Secreted proteins and polynucleotides encoding them
11/05/1998WO1998034602A3 Mediation of cytokines by melanin
11/05/1998WO1998013349A3 Heteroaryloxyethylamines as 5-ht1a ligands
11/05/1998DE19718334A1 Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New benzylamine derivatives and phenylethylamine derivatives, processes for their preparation and their use as medicaments
11/05/1998CA2720332A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/05/1998CA2614617A1 Pourable alginate compositions
11/05/1998CA2288073A1 Human lysophospholipase
11/05/1998CA2287989A1 Protease inhibitors
11/05/1998CA2287567A1 Protease inhibitors
11/05/1998CA2287436A1 Spiro-azacyclic derivatives and their use as therapeutic agents
11/05/1998CA2278217A1 Phosphodiesterase 4-inhibiting diazepinoindolones
11/04/1998EP0875565A2 Novel G-protein coupled receptor (hfgan72y)
11/04/1998EP0875501A2 Alkylenediamine derivative, anti-ulcer drug, and antibacterial drug
11/04/1998EP0874849A1 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives
11/04/1998EP0874843A1 Novel substituted 4-(1h-benzimidazol-2-yl) 1,4]diazepanes useful for the treatment of allergic diseases
11/04/1998EP0874833A1 4,5-dihydronaphth 1,2-c]isoxazoles and derivatives thereof having cns activity
11/04/1998EP0874824A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
11/04/1998EP0874823A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
11/04/1998EP0874819A1 Imides as pde iii, pde iv and tnf inhibitors
11/04/1998EP0874818A1 Novel substituted aryl compounds useful as modulators of acetylcholine receptors
11/04/1998EP0874636A1 Tea, kit and method for treating hemorrhoids
11/04/1998EP0874621A1 Pharmaceutical compositions
11/04/1998EP0874558A1 Liquid oral compositions comprising a calcium compound and an acidulant
11/04/1998EP0619802B1 A mixture of higher primary aliphatic alcohols and its pharmaceutical uses
11/04/1998CN1198096A C-proteinase inhibitor for treatment of disorders related to overproduction of collagen
11/04/1998CN1197673A Chinese medicine 'Xiaoyangtang' for curing acute and chronic hepatitis B
11/04/1998CN1197669A Medicine for Meniere's disease
11/03/1998US5831022 Interleukins
11/03/1998US5830915 Oral diseases; skin disorders; antiinflammatory agents
11/03/1998US5830906 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
11/03/1998US5830903 Triazole substituted quinoline derivatives for gastrointestinal treat-treatment
11/03/1998US5830892 Piperidine and morphonline derivatives and their use as therapeutic agents
11/03/1998US5830887 Cancer, pms, menopause and hypercholesterolemia
11/03/1998US5830710 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
11/03/1998US5830671 Method for assaying for modulators of cytokines of the TFG β superfamily
11/03/1998US5830489 Protein preparation for the prevention and therapy of periodontitis
11/03/1998US5830455 Method of treatment using a therapeutic combination of α interferon and free radical scavengers
10/1998
10/30/1998CA2231741A1 Novel g-protein coupled receptor (hfgan72y)
10/29/1998WO1998047898A1 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
10/29/1998WO1998047892A1 Substituted imidazoles useful in the treatment of inflammatory diseases
10/29/1998WO1998047879A1 Substituted phenyl derivatives, their preparation and use
10/29/1998WO1998047874A1 Crf antagonistic quino- and quinazolines
10/29/1998WO1998047511A1 Use of mizolastine for preparing a medicine for treating inflammation
10/29/1998WO1998047501A1 Pharmaceutical preparation containing nimesulide for oral administration
10/29/1998WO1998047481A1 Use of 5ht3 antagonists for promoting intestinal lavage
10/29/1998WO1998047480A2 Membrane system for controlled tissue regeneration in cases of diseases of the peridontium
10/29/1998WO1998041538A3 Novel human cytokine/steroid receptor protein
10/29/1998WO1998034121A3 Isolated p27 protein and methods for its production and use
10/29/1998WO1998025613A3 Galenic composition containing opioid antagonists
10/29/1998DE19716660A1 Herbal preparation for treating Helicobacter pylori infections
10/29/1998CA2297176A1 Substituted imidazoles useful in the treatment of inflammatory diseases
10/29/1998CA2286106A1 5-aryl-3-(8-azabicyclo(3.2.1)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
10/29/1998CA2285424A1 Substituted phenyl derivatives, their preparation and use
10/28/1998EP0873755A1 Prevention and treatment of enterohemorrhagic E. coli infection
10/28/1998EP0873753A1 Use of NK-1 receptor antagonists for the manufacture of a medicament in the treatment of symptoms of irritable bowel syndrome
10/28/1998EP0873408A1 Calcium binding proteolipid compositions and methods
10/28/1998EP0873336A1 Antagonists of gonadotropin releasing hormone
10/28/1998EP0873330A1 Diarylalkenylamine derivatives
10/28/1998EP0873320A1 Piperazine derivatives as tachykinin antagonists
10/28/1998EP0873309A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
10/28/1998EP0873050A1 Pharmaceutical compositions for prevention and treatment of ulcerative colitis
10/28/1998EP0701565B1 New prednisolone derivates
10/28/1998CN1196947A Anti-bacterium stomach curative capsules
10/27/1998US5827869 Substituted biphenyl isoxazole sulfonamides
10/27/1998US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology
10/27/1998US5827526 Administering the fructooligosaccharides, nystose and 1f-beta-fructofuranosyl nystose; infants
10/27/1998US5827517 CCK antibodies used to improve feed efficiency
10/27/1998CA2102179C Quinuclidine derivatives
10/23/1998CA2235457A1 Prevention and treatment of enterohemorrhagic e. coli infection
10/23/1998CA2235438A1 Nk-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome
10/22/1998WO1998046761A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
10/22/1998WO1998046758A1 Human tumor-associated kazal inhibitor
10/22/1998WO1998046746A1 Extracellular/epidermal growth factor like protein
10/22/1998WO1998046642A1 MODIFIED TNFα MOLECULES, DNA ENCODING SUCH MODIFIED TNFα MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFα MOLECULES AND DNA
10/22/1998WO1998046633A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
1 ... 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 ... 1258